Elutia, Inc. (ELUT)
0.8392
+0.02
(+2.34%)
USD |
NASDAQ |
Nov 16, 13:38
Elutia Shareholders Equity (Quarterly) : 15.32M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 15.32M |
| June 30, 2026 | 15.75M |
| March 31, 2026 | 22.53M |
| December 31, 2025 | 27.67M |
| September 30, 2025 | -43.92M |
| June 30, 2025 | -41.84M |
| March 31, 2025 | -36.46M |
| December 31, 2024 | -46.26M |
| September 30, 2024 | -40.24M |
| June 30, 2024 | -64.34M |
| March 31, 2024 | -50.30M |
| December 31, 2023 | -38.60M |
| September 30, 2023 | -29.47M |
| Date | Value |
|---|---|
| June 30, 2023 | -22.13M |
| March 31, 2023 | -12.18M |
| December 31, 2022 | -5.033M |
| September 30, 2022 | -10.68M |
| June 30, 2022 | -1.369M |
| March 31, 2022 | 6.559M |
| December 31, 2021 | 13.52M |
| September 30, 2021 | 7.859M |
| June 30, 2021 | 14.97M |
| March 31, 2021 | 16.44M |
| December 31, 2020 | 20.83M |
| September 30, 2020 | -74.90M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -105.37M |
| Amgen, Inc. | 14.35B |
| Anika Therapeutics, Inc. | 137.58M |
| BioCryst Pharmaceuticals, Inc. | -397.38M |
| Imunon, Inc. | 2.622M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 48.19M |
| Total Liabilities (Quarterly) | 32.87M |
| Debt to Equity Ratio | 1.046 |
| Current Ratio | 2.630 |
| Net Debt Paydown Yield | 12.15% |